These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 33068862)
1. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer. Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer. Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297 [TBL] [Abstract][Full Text] [Related]
4. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. Cabrero-de Las Heras S; Martínez-Balibrea E World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461 [TBL] [Abstract][Full Text] [Related]
5. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors. Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842 [TBL] [Abstract][Full Text] [Related]
6. IL-17 inhibits CXCL9/10-mediated recruitment of CD8 Chen J; Ye X; Pitmon E; Lu M; Wan J; Jellison ER; Adler AJ; Vella AT; Wang K J Immunother Cancer; 2019 Nov; 7(1):324. PubMed ID: 31775909 [TBL] [Abstract][Full Text] [Related]
7. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis. Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978 [TBL] [Abstract][Full Text] [Related]
8. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines. Sun X; Chen Q; Zhang L; Chen J; Zhang X Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533 [TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival. Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E Front Immunol; 2021; 12():778329. PubMed ID: 34975867 [TBL] [Abstract][Full Text] [Related]
10. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment. Yin Z; Ma T; Chen S; Yu M Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8 Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and Immunological Role of THBS2 in Colorectal cancer. Deng B; Liu XP; Wang X Biomed Res Int; 2021; 2021():1124985. PubMed ID: 34471634 [TBL] [Abstract][Full Text] [Related]
13. The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer. Li X; Zhong Q; Luo D; Du Q; Liu W PLoS One; 2019; 14(4):e0214611. PubMed ID: 30973890 [TBL] [Abstract][Full Text] [Related]
14. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells. Zhang Z; Tan X; Luo J; Cui B; Lei S; Si Z; Shen L; Yao H Cancer Med; 2018 Nov; 7(11):5611-5620. PubMed ID: 30267476 [TBL] [Abstract][Full Text] [Related]
15. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment. Zhou X; Peng M; He Y; Peng J; Zhang X; Wang C; Xia X; Song W Front Oncol; 2021; 11():619003. PubMed ID: 33767987 [TBL] [Abstract][Full Text] [Related]
16. CXCL9 chemokine promotes the progression of human pancreatic adenocarcinoma through STAT3-dependent cytotoxic T lymphocyte suppression. Gao HF; Cheng CS; Tang J; Li Y; Chen H; Meng ZQ; Chen Z; Chen LY Aging (Albany NY); 2020 Jan; 12(1):502-517. PubMed ID: 31913856 [TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis. Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008 [TBL] [Abstract][Full Text] [Related]
19. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400 [TBL] [Abstract][Full Text] [Related]
20. The expression and role of CXC chemokines in colorectal cancer. Verbeke H; Struyf S; Laureys G; Van Damme J Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]